BML reports 2.20M shares (11.8%) in Outset Medical

Outset Medical, Inc. filing an amendment to a Schedule 13G that updates beneficial ownership for BML Investment Partners, L.P.

Rhea-AI Filing Summary

Outset Medical, Inc. filing an amendment to a Schedule 13G that updates beneficial ownership for BML Investment Partners, L.P. The filing reports 2,196,701 shares of Common Stock and a 11.8% ownership stake, with shared voting and dispositive power reported.

The filing states that BML Investment Partners, L.P. is a Delaware limited partnership; BML Capital Management, LLC is its sole general partner and Braden M. Leonard is the managing member, who is deemed an indirect owner of the reported shares. The signature is dated 05/12/2026.

Key Figures

Shares beneficially owned: 2,196,701 shares Percent of class: 11.8% CUSIP: 690145206 +3 more

6 metrics

Shares beneficially owned 2,196,701 shares Amount beneficially owned reported in Schedule 13G/A

Percent of class 11.8% Percent of common stock reported in Item 4(b)

CUSIP 690145206 CUSIP for Outset Medical common stock as listed on cover

Signature date 05/12/2026 Date on signature block for the amendment

Shared voting power 2,196,701 shares Item 4(c)(ii) reports shared power to vote

Shared dispositive power 2,196,701 shares Item 4(c)(iv) reports shared power to dispose

Key Terms

Beneficially owned, Shared Dispositive Power, Schedule 13G/A, statutory group, +1 more

5 terms

Beneficially owned regulatory

"Item 4. | Ownership (a) | Amount beneficially owned: 2196701"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared Dispositive Power regulatory

"(iv) Shared power to dispose or to direct the disposition of: 2196701"

Schedule 13G/A regulatory

"(Amendment No. 2 ) Outset Medical, Inc."

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

statutory group regulatory

"the reporting persons disclaim that they constitute a statutory group"

CUSIP other

"CUSIP No.: 690145206"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does BML Investment Partners report in Outset Medical (OM)?

BML Investment Partners reports 2,196,701 shares, representing 11.8% of Outset Medical’s common stock. The filing lists this amount as beneficially owned and ties the percentage to the class of common stock.

Who is the ultimate reporting person for the 13G/A amendment for OM?

BML Investment Partners, L.P. is the filing entity; its sole general partner is BML Capital Management, LLC and the managing member is Braden M. Leonard, who is deemed an indirect owner of the reported shares.

What voting and dispositive powers are disclosed in the OM Schedule 13G/A?

The filing discloses shared voting power of 2,196,701 shares and shared dispositive power of 2,196,701 shares. It lists zero sole voting and zero sole dispositive power for the reporting person.

When was the Schedule 13G/A amendment signed for OM?

The signature block shows the filing was signed by Braden M. Leonard on 05/12/2026. The filing identifies the reporting persons and their organizational relationships in the accompanying signature comments.

Does the 13G/A state the reporting persons form a statutory group?

The filing explicitly states the reporting persons disclaim that they constitute a statutory group under Rule 13d-5(b)(1). The comment appears in the signature block accompanying the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 04:41 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Outset Medical, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

690145206

(CUSIP Number)

05/11/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 690145206

1

Names of Reporting Persons

BML Investment Partners, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,196,701.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,196,701.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,196,701.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.8 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Outset Medical, Inc.
(b)	Address of issuer's principal executive offices: 3052 Orchard Dr., San Jose, United States, 95134
Item 2.
(a)	Name of person filing: BML Investment Partners, L.P.
(b)	Address or principal business office or, if none, residence: 65 E Cedar - Suite 2, Zionsville IN 46077
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 690145206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2196701
(b)	Percent of class: 11.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2196701
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2196701
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BML Investment Partners, L.P.

Signature:	Braden M Leonard
Name/Title:	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:	05/12/2026

Comments accompanying signature: BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.